Decreasing initial hospitalization of the cyclosporine-treated renal allograft recipient is safe.
Koyle
M A
MA
Department of Surgery, Harbor/UCLA Medical Center, Torrance 90509.
Rosen
M
M
Sender
M B
MB
Rajfer
J
J
Glassock
R J
RJ
Ward
H J
HJ
D003365:Costs and Cost Analysis; D003524:Cyclosporins / Q000627:therapeutic use*; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics; D016030:Kidney Transplantation; D011182:Postoperative Care; D013997:Time Factors
D003524:Cyclosporins